1 |
Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant[J]. N Engl J Med, 1999, 341(23): 1725-1730.
|
2 |
Abuanzeh R, Hashmi F, Dimarakis I, et al. Early donor management increases the retrieval rate of hearts for transplantation in marginal donors[J]. Eur J Cardiothorac Surg, 2015, 47(1): 72-77.
|
3 |
Maciel CB, Greer DM. ICU Management of the Potential Organ Donor: State of the Art[J]. Curr Neurol Neurosci Rep, 2016, 16(9): 86.
|
4 |
Citerio G, Cypel M, Dobb GJ, et al. Organ donation in adults: a critical care perspective[J]. Intensive Care Med, 2016, 42(3): 305-315.
|
5 |
中华人民共和国国家卫生和计划生育委员会, 国家卫生计生委医政医管局. 卫生部办公厅关于启动心脏死亡捐献器官移植试点工作的通知[EB/OL]. (2011-05-03)
URL
|
6 |
霍枫,汪邵平,李鹏, 等. 公民心死亡器官捐献肝移植[J]. 中华消化外科杂志, 2012, 11(1): 69-72.
|
7 |
Shemie SD, Hornby L, Baker A, et al. International guideline development for the determination of death[J]. Intensive Care Med, 2014, 40(6): 788-797.
|
8 |
Potts JT, Herdman R. Non-Heart-Beating Organ Transplantation: Medical and Ethical Issues in Procurement[M]. Washington (DC): National Academies Press (US), 1997.
|
9 |
国家卫生和计划生育委员会脑损伤质控评价中心. 脑死亡判定标准与技术规范(成人质控版)[J]. 中国现代神经疾病杂志, 2015, 15(12): 935-939.
|
10 |
Bugedo G, Bravo S, Romero C, et al. [Management of the potential organ donor][J]. Rev Med Chil, 2014, 142(12): 1584-1593.
|
11 |
Anthony DC, Couch Y, Losey P, et al. The systemic response to brain injury and disease[J]. Brain Behav Immun, 2012, 26(4): 534-540.
|
12 |
Watts RP, Thom O, Fraser JF. Inflammatory signalling associated with brain dead organ donation: from brain injury to brain stem death and posttransplant ischaemia reperfusion injury[J]. J Transplant, 2013, 2013: 521369.
|
13 |
Smith M. Physiologic changes during brain stem death--lessons for management of the organ donor[J]. J Heart Lung Transplant, 2004, 23(9 Suppl): S217-S222.
|
14 |
Chen EP, Bittner HB, Kendall SW, et al. Hormonal and hemodynamic changes in a validated animal model of brain death[J]. Crit Care Med, 1996, 24(8): 1352-1359.
|
15 |
Al-Khafaji A, Elder M, Lebovitz D J, et al. Protocolized fluid therapy in brain-dead donors: the multicenter randomized MOnIToR trial[J]. Intensive Care Medicine, 2015, 41(3): 418-426.
|
16 |
Kotloff RM, Blosser S, Fulda GJ, et al. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement[J]. Crit Care Med, 2015, 43(6): 1291-1325.
|
17 |
Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor[J]. N Engl J Med, 2004, 351(26): 2730-2739.
|
18 |
Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial[J]. JAMA, 2009, 302(10): 1067-1075.
|
19 |
Wang Z, Guan W, Han Y, et al. Stimulation of Dopamine D3 Receptor Attenuates Renal Ischemia-Reperfusion Injury via Increased Linkage With Galpha12[J]. Transplantation, 2015, 99(11): 2274-2284.
|
20 |
Munshi L, Keshavjee S, Cypel M. Donor management and lung preservation for lung transplantation[J]. Lancet Respir Med, 2013, 1(4): 318-328.
|
21 |
Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial[J]. JAMA, 2010, 304(23): 2620-2627.
|
22 |
Minambres E, Perez-Villares JM, Chico-Fernandez M, et al. Lung donor treatment protocol in brain dead-donors: A multicenter study[J]. J Heart Lung Transplant, 2015, 34(6): 773-780.
|
23 |
Minambres E, Ballesteros MA, Rodrigo E, et al. Aggressive lung donor management increases graft procurement without increasing renal graft loss after transplantation[J]. Clin Transplant, 2013, 27(1): 52-59.
|
24 |
Prodhan P, Casavant D, Medlock MD, et al. Inhaled nitric oxide in neurogenic cardiopulmonary dysfunction: implications for organ donation[J]. Transplant Proc, 2004, 36(9): 2570-2572.
|
25 |
Ware LB, Landeck M, Koyama T, et al. A randomized trial of the effects of nebulized albuterol on pulmonary edema in brain-dead organ donors[J]. Am J Transplant, 2014, 14(3): 621-628.
|
26 |
Levin K, Kotecha S, Westall G, et al. How can we improve the quality of transplantable lungs[J]? Expert Rev Respir Med, 2016, Oct 3: 1-7.
|
27 |
Dikdan GS, Mora-Esteves C, Koneru B. Review of randomized clinical trials of donor management and organ preservation in deceased donors: opportunities and issues[J]. Transplantation, 2012, 94(5): 425-441.
|
28 |
Sharpe MD, van Rassel B, Haddara W. Oral and intravenous thyroxine (T4) achieve comparable serum levels for hormonal resuscitation protocol in organ donors: a randomized double-blinded study[J]. Can J Anaesth, 2013, 60(10): 998-1002.
|
29 |
Pinsard M, Ragot S, Mertes PM, et al. Interest of low-dose hydrocortisone therapy during brain-dead organ donor resuscitation: the CORTICOME study[J]. Crit Care, 2014, 18(4): R158.
|
30 |
Mi Z, Novitzky D, Collins JF, et al. The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors[J]. Clin Epidemiol, 2014, 7: 17-27.
|
31 |
Lumbreras C, Sanz F, Gonzalez A, et al. Clinical significance of donor-unrecognized bacteremia in the outcome of solid-organ transplant recipients[J]. Clin Infect Dis, 2001, 33(5): 722-726.
|
32 |
Singh N. Impact of donor bacteremia on outcome in organ transplant recipients[J]. Liver Transpl, 2002, 8(10): 975-976.
|
33 |
Fishman JA, Greenwald MA, Grossi PA. Transmission of infection with human allografts: essential considerations in donor screening[J]. Clin Infect Dis, 2012, 55(5): 720-727.
|
34 |
Westphal GA, Garcia VD, Souza RL, et al. Guidelines for the assessment and acceptance of potential brain-dead organ donors[J]. Rev Bras Ter Intensiva, 2016, 28(3): 220-255.
|
35 |
Lewis JD, Sifri CD. Multidrug-Resistant Bacterial Donor-Derived Infections in Solid Organ Transplantation[J]. Curr Infect Dis Rep, 2016, 18(6): 18.
|
36 |
Simkins J, Muggia V. Favorable outcome in a renal transplant recipient with donor-derived infection due to multidrug-resistant Pseudomonas aeruginosa[J]. Transpl Infect Dis, 2012, 14(3): 292-295.
|
37 |
Fischer SA, Lu K. Screening of donor and recipient in solid organ transplantation[J]. Am J Transplant, 2013, 13 Suppl 4: 9-21.
|
38 |
McKeown DW, Bonser RS, Kellum JA. Management of the heartbeating brain-dead organ donor[J]. Br J Anaesth, 2012, 108 Suppl 1: i96-i107.
|
39 |
Niemann CU, Feiner J, Swain S, et al. Therapeutic Hypothermia in Deceased Organ Donors and Kidney-Graft Function[J]. N Engl J Med, 2015, 373(5): 405-414.
|
40 |
Fan X, Chen Z, Nasralla D, et al. The organ preservation and enhancement of donation success ratio effect of extracorporeal membrane oxygenation in circulatory unstable brain death donor[J]. Clin Transplant, 2016, 30(10): 1306-1313.
|
41 |
Migliaccio ML, Zagli G, Cianchi G, et al. Extracorporeal membrane oxygenation in brain-death organ and tissues donors: a single-centre experience[J]. Br J Anaesth, 2013, 111(4): 673-674.
|
42 |
Teng-Wei C, Chung-Bao H, Chan DC, et al. Marked elevation of hepatic transaminases in recipients of an orthotopic liver transplant from a brain-dead donor receiving extracorporeal membrane oxygenation[J]. Ann Transplant, 2014, 19: 680-687.
|
43 |
Bernat JL, Capron AM, Bleck TP, et al. The circulatory-respiratory determination of death in organ donation[J]. Crit Care Med, 2010, 38(3): 963-970.
|
44 |
Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation[J]. Am J Transplant, 2009, 9(9): 2004-2011.
|
45 |
Detry O, Le Dinh H, Noterdaeme T, et al. Categories of donation after cardiocirculatory death[J]. Transplant Proc, 2012, 44(5): 1189-1195.
|
46 |
Bernat JL, D′Alessandro AM, Port FK, et al. Report of a National Conference on Donation after Cardiac Death[J]. Am J Transplant, 2006, 6(2): 281-291.
|
47 |
Maciel CB, Hwang DY, Greer DM. Organ donation protocols[J]. Handb Clin Neurol, 2017, 140: 409-439.
|